A Phase I Study of SIM0388 in Participants With Malignant Ascites. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase I Study of SIM0388 in Participants With Malignant Ascites. — Stella

Recruiting

Back to Malignant Ascites trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

China

Shanghai Gobroad Cancer Hospital, Shanghai, Shanghai Municipality

Key details

Phase

First-in-human testing

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Enrollment target

~50 participants

Started

April 2025

Primary completion

June 2027

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov